Massimo Andreoni

12PUBLICATIONS
74CO-AUTHORS
Nanotoxicology, health and safetyMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Medical microbiology not elsewhere classifiedMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 28, 2025
Pharmacological and Adjunctive Management of Non-Hospitalized COVID-19 Patients During the Omicron Era: A Systematic Review and Meta-Analysis.

Lorenzo Vittorio Rindi, Drieda Zaçe, Loredana Sarmati

|Aug 20, 2025
Facing antimicrobial resistance in cancer care: what the AIOM survey tells us about oncologists' awareness.

A Lasagna, P Cambieri, S Figini

|Feb 20, 2025
How Should We Manage the Impact of Antimicrobial Resistance in Patients With Cancer? An Oncological and Infectious Disease Specialist Point of View.

Angioletta Lasagna, Patrizia Cambieri, Fausto Baldanti

|Jan 20, 2024
Brain abscess caused by Actinomyces turicensis in a non-immunocompromised adult patient: a case report and systematic review of the literature.

Alessandra Imeneo, Lorenzo Vittorio Rindi, Andrea Di Lorenzo

|Dec 29, 2023
Real-life Data on Cefiderocol Efficacy and Safety to Treat Multidrug-Resistant Acinetobacter baumannii Infections.

Laura Campogiani, Angela Maria Antonia Crea, Maria Letizia Minardi

|Feb 07, 2023
Admission eGFR predicts in-hospital mortality independently of admission glycemia and C-peptide in patients with type 2 diabetes mellitus and COVID-19.

Marco Infante, Massimo Pieri, Santina Lupisella

Pageof 2

Frequent Collaborators

4 joint publications

Marco Iannetta

3 joint publications

Loredana Sarmati

2 joint publications

Francesco Perrone

2 joint publications

Fulvio Adorni